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ABSTRACT
Background: The role of an adverse maternal environment (AME) in conjunction with a postweaning Western diet
(WD) in the development of nonalcoholic fatty liver disease (NAFLD) in adult offspring has not been explored. Likewise,
the molecular mechanisms associated with AME-induced NAFLD have not been studied. The fatty acid translocase or
cluster of differentiation 36 (CD36) has been implicated to play a causal role in the pathogenesis of WD-induced steatosis.
However, it is unknown if CD36 plays a role in AME-induced NAFLD.
Objective: This study was designed to evaluate the isolated and additive impact of AME and postweaning WD on
the expression and DNA methylation of hepatic Cd36 in association with the development of NAFLD in a novel mouse
model.
Methods: AME constituted maternal WD and maternal stress, whereas the control (Con) group had neither. Female
C57BL/6J mice were fed a WD [40% fat energy, 29.1% sucrose energy, and 0.15% cholesterol (wt/wt)] 5 wk prior to
pregnancy and throughout lactation. Non invasive variable stressors (random frequent cage changing, limited bedding,
novel object, etc.) were applied to WD dams during the last third of pregnancy to produce an AME. Con dams consumed
the control diet (CD) (10% fat energy, no sucrose or cholesterol) and were not exposed to stress. Male offspring were
weaned onto either CD or WD, creating 4 experimental groups: Con-CD, Con-WD, AME-CD, and AME-WD, and evaluated
for metabolic and molecular parameters at 120 d of age.
Results: AME and postweaning WD independently and additively increased the development of hepatic steatosis in
adult male offspring. AME and WD independently and additively upregulated hepatic CD36 protein and mRNA expression
and hypomethylated promoters 2 and 3 of the Cd36 gene.
Conclusions: Using a mouse AME model together with postweaning WD, this study demonstrates a role for CD36
in AME-induced NAFLD in offspring and reveals 2 regions of environmentally induced epigenetic heterogeneity within
Cd36. J Nutr 2021;151:3102–3112.
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Introduction
The incidence of NAFLD is steadily increasing and occurs in
∼30% of Americans (1–3). Consumption of a high-fat diet
(HFD) or Western diet (WD) contributes to the development
of NAFLD. Interestingly, the incidence of adult NAFLD
also increases following exposure to an adverse maternal
environment (AME) (4–9). It is unclear if the development of

NAFLD following an AME occurs via a similar mechanism to
diet- related NAFLD.
The development of NAFLD following the consumption of
HFD or WD occurs in part through the hepatic uptake of
fatty acids in excess of metabolic requirements. Excess fatty
acids are then stored inside hepatocytes and result in steatosis
(10). Increasing numbers of studies have shown the role of the
fatty acid translocase or cluster of differentiation 36 (CD36) in
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Methods
Animals
All animal procedures were approved by the Medical College of
Wisconsin Institutional Animal Care and Use Committee. This mouse
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model of AME has been previously published by our group (34). Briefly,
Female C57BL/6J mice were maintained with standard light cycles at
a constant temperature of 23◦ C with food and water available ad
libitum. The mice were randomly allocated to either an experimental
WD or a control diet (CD) (Table 1 and Supplemental Table 1).
The WD (D12079B, Research Diets, New Brunswick, NJ) has been
previously published by other groups (35). It contained increased fat
(40% compared with 10% in kcal), sucrose (29.1% compared with
0% in kcal), and cholesterol [0.15% compared with 0% (wt/wt)]
compared with the CD (D14020502, Research Diets). The diets were
provided for 5 wk before the females were mated with males receiving
Laboratory Rodent Diet (5L0D, LabDiet), throughout pregnancy, and
during lactation.
Dams fed the WD experienced a “stressed” environment during the
last third of pregnancy. The combination of chronic WD and gestational
stress is designated as AME (34). Briefly, the stressed environment
consisted of daily random environmental changes as well as a static
change in the maternal environment consisting of one-third of the
standard amount of bedding from embryonic day (E)13 to E19. The
daily random environmental changes included altered light cycles on
3 nonconsecutive d, 3 repeat cage changes throughout the day on
E15, and the short-term introduction of a novel object in the cage
for a day. Control (Con) dams consumed CD and were not exposed
to stress (34). Food intake in dams was recorded from E6 through
E19. At the end of pregnancy, 6 pregnant female mice from both
Con and AME groups were anesthetized with isoflurane and killed
by decapitation after 5 h of fasting. Trunk blood and serum were
collected for the measurement of corticosterone. On postnatal day
5, litters were randomly culled to 6, 3 of each sex. Male offspring
from both the Con and AME dams were weaned onto either the CD
or WD, generating 4 experimental groups: Con-CD, Con-WD, AMECD, and AME-WD (34). At the age of 120 d (n = 6 litters of each
of the 4 groups, respectively) mice were anesthetized with isoflurane
and killed by decapitation after 5 h of fasting. Trunk blood and
serum were collected. Fasting glucose was measured using a OneTouch
Verio IQ meter (LifeScan Inc.). Retroperitoneal fat pads and livers
were quickly removed, and the wet weights were recorded. A piece
of the right medial lobe of the liver was fixed in 10% formalin,
the remaining liver was flash frozen in liquid nitrogen and stored in
−80◦ C.

Serum concentrations of corticosterone, insulin, and
alanine transaminase
Dam serum concentrations of corticosterone were measured by using a
corticosterone enzyme immunoassay kit (Cat# K014-H1, Arbor assays)
per the manufacturer’s instructions.
Serum insulin was measured via the ELISA method using a
Rat/Mouse Insulin ELISA kit (EMD Millipore) according to manufacturer’s recommendations. HOMA-IR is widely used clinically for the
diagnosis of human insulin resistance (IR). It has been validated in rats
(36–38). It has been used as a diagnostic criterion for IR in mice studies,
although it has not been validated in mice (39–42). HOMA-IR was
calculated by using fasting insulin and fasting glucose In the following
equation: HOMA-IR = fasting plasma insulin (in milliunits per liter) ×
fasting glucose (in millimoles per litter)/22.5 (43).
Serum ALT was measured by using EnzyChrom Alan Transaminase
Assay Kit (BioAssay Systems) per the manufacturer’s recommendations.

Glucose tolerance test (GTT)
The glucose tolerance test (GTT) was performed at week 14 of life
after 6 h of fasting. Fasting glucose (time 0) was measured followed
by intraperitoneal injection of glucose 60 mg in 20% (wt/vol) solution.
The fixed dose of glucose was calculated as 2 g/kg of mean body
weight of the Con-CD mice, based on the recommendations of the
NIH Mouse Metabolic Phenotyping Center Consortium (44, 45).
Glucose concentrations at 15, 30, 60, 90, and 120 min after glucose
injection were measured using a OneTouch Verio IQ meter. Serum
insulin was measured using ELISA at 60 min after glucose injection,
as aforementioned.
Expression and DNA methylation of Cd36 in NAFLD
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driving the onset of hepatic steatosis (4, 11, 12). CD36 plays a
key role in increasing fatty acid uptake in hepatocytes and other
cell types in the liver (10, 13, 14).
CD36 is a member of the class B scavenger receptor family
and mediates long-chain fatty acid uptake in many tissues
(15). CD36 also regulates lipid homeostasis in many cell types
through multiple mechanisms, including regulation of fatty acid
oxidation (16), VLDL secretion (17), and lipophagy (18). CD36
expression is low in hepatocytes but increases with lipid-rich
diets and in NAFLD in both human and mouse models (19–23).
A liver-specific Cd36 knockout attenuates steatosis in mouse
models of NAFLD (4, 12). Overexpression of hepatic CD36
resulted in a marked increase in hepatic fatty acid uptake and
storage in both primary cultured hepatocytes and mouse livers
(11). These indicate that CD36 expression has significant effects
on liver lipid content and plays a causal role in the pathogenesis
of NAFLD.
Multiple groups have studied the impact of maternal HFD
or WD on the development of NAFLD in offspring in animal
models (24–30). The offspring from these models developed
NAFLD when fed a postweaning HFD or WD (5–9, 31).
Despite this appreciation for the maternal and dietary impact
on NAFLD, none of these studies ascertained if CD36 plays a
role in AME-induced NAFLD.
To identify a mechanism through which relevant environmental stimuli alter CD36 expression, we have generated a
novel AME model by combining long-term maternal WD
and maternal stress. This combination of diet and stress was
thoughtfully developed to model 2 of the most common environmental pressures during pregnancy as well as important factors for the development of NAFLD. Importantly, these factors
are also modifiable and translatable from animals to humans.
Epigenetics, such as DNA methylation, provide insights
into the mechanisms of early life predisposition to adult
disease risk (32, 33). Understanding these epigenetic changes
is important not only to understanding the mechanisms at
play, but may also provide a molecular marker of potential
disease. We hypothesized that, like HFD, AME induction of
NAFLD will increase CD36 expression and that the addition
of a postweaning WD will further increase CD36 expression
and NAFLD. Additionally, AME-driven increase in CD36 will
be accompanied by decreased methylation at key regulatory
regions of Cd36.

TABLE 1 Compositions of experimental diets
Diet
CD
Ingredients

g

kcal

g

kcal

195
3
695
150
0
35.5
17
50
35
4
10
2
0
1196.6
17
71
4
3.9

780
12
2780
600
0
320
153
0
0
0
40
0
0
4685
17
73
10

195
3
50
100
341
200
10
50
35
4
10
2
1.5
1001.5
20
50
21
4.7

780
12
200
400
1364
1800
90
0
0
0
40
0
0
4686
17
43
40

CD, control diet (D14020502, Research Diets); WD, Western diet (D12079B, Research Diets).

Hepatic histology
Livers were fixed in 10% formalin and paraffin embedded.
Slices (4 μm) were stained by hematoxylin and eosin and Masson’s
trichrome. The NAFLD activity score (NAS) was proposed by the
NIDDK-sponsored NASH Clinical Research Network and has been
widely used for clinical trials in patients since its validation (46). NAS
was evaluated by a pathologist blinded to the experimental groups
by using the Kleiner scoring system (46). The score is defined as the
unweighted sum of the scores for steatosis (0–3), lobular inflammation
(0–3), and ballooning (0–2). A minimum of 5% steatosis (steatosis score
of 1) was used for the operational minimal definition of histological
NAFLD. NAS scores of 1–2 were largely considered mild NAFLD and
3–4 as moderate NAFLD. An NAS score of <2 was diagnosed as “not
nonalcoholic steatohepatitis (NASH).” A score of ≥5 is interpreted as
NASH.

RNA isolation
Total RNA isolation was performed by using an miRNeasy Mini Kit
(Qiagen) following the manufacturer’s instructions, including DNase I
treatment. RNA was quantified spectrophotometrically. The integrity
of RNA was assessed with an Agilent 2100 bioanalyzer in conjunction
with the RNA 6000 Nano Kit (Agilent).

RT-PCR
cDNA was synthesized using a High-Capacity cDNA Reverse Transcription Kit (Applied Biosystems, Thermo Fisher Scientific). Realtime RT-PCR was performed as described earlier (47). Target primers
and probes were either custom designed using the online PrimerQuest
Tool [Integrated DNA Technologies (IDT)], or predesigned probebased assays from IDT or Applied Biosystems, ThermoFisher Scientific
(Supplemental Table 2). Real-time RT-PCR was performed on a ViiA
7 Real-Time PCR System (Applied Biosystems) in conjunction with a
PrimeTime Gene Expression Master Mix (IDT). PCR conditions were
95◦ C for 10 min, followed by 40 cycles of 95◦ C for 15 s, and 60◦ C for
1 min. Samples were run in triplicate. Real-time RT-PCR quantitation
was performed using hypoxanthine guanine phosphoribosyl transferase
(Hprt) as an internal control. Based on the expression stability between
experimental groups, Hprt was chosen as the internal control after
assessing both Hprt and glyceraldehyde-3-phosphate dehydrogenase
(Gapdh) as candidate housekeeping genes. Relative quantification of
3104
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PCR products was based on value differences between the target and
Hprt control using the comparative Ct method.
Cd36 mRNA variants were also quantified in the methods shown
above using custom designed or predesigned primers/probes (Supplemental Table 2 and Supplemental Figure 1). Agarose electrophoresis
of the PCR products of transcripts initiated from promoter 1 (P1
transcripts) revealed 2 bands, as did P2 transcripts. Each band was gel
purified using a QIAquick Gel Extraction Kit (Qiagen). Sequences were
confirmed by Sanger sequencing (Retrogen, Inc.). No specific assays can
be designed for P3 transcripts because both P1 and P2 transcripts have
1 variant that crosses the exon 3–4 junction. We therefore calculated
the relative amount of P3 transcripts by subtracting 2(-Ct (P1 transcripts –
Hprt)) and 2[-Ct (P2 transcripts – Hprt)] from the 2[-Ct (total CD36 – Hprt)] .

Membrane protein extraction and immunoblotting
Liver membrane protein was extracted using a Mem-PER Plus
Membrane Protein Extraction Kit (Thermo Scientific) and quantified
using a Pierce BCA Protein Assay Kit (Thermo Scientific).
Quantification of CD36 membrane protein was done using capillary
immunoassay. Protein was separated and detected using a Wes
Separation Capillary Cartridge 12–230 kDa along with a Wes AntiRabbit Detection Module (Simple Western system and Compass
Software, Proteinsimple). Membrane protein samples were loaded at
a 0.2-mg/mL dilution and rabbit antibody was used against CD36
(1:500) (ab133625, abcam) and pan Cadherin (1:5,000) (ab51034,
abcam). Chemiluminescent signals shown as the peak area for antiCD36 relative to that for anti-pan Cadherin were used as the levels of
membrane CD36 protein relative to that of pan Cadherin.

Immunohistochemistry
Immunohistochemistry (IHC) analysis and staining were performed
on formalin-fixed paraffin-embedded (FFPE) sections of mouse livers
using the Bond RX autostainer platform (Leica Biosystems Inc.) in
the Children’s Research Institute Histology Core in Medical College
of Wisconsin. Deparaffined sections underwent heat-induced epitope
retrieval (Cat. No. S1699, pH 6.0, Agilent Dako) at 100◦ C for 20 min.
The primary antibody was anti-CD36 rabbit monoclonal antibody
(Cat. No. ab133625, abcam) at 1:100 dilution. Bound antibody
was detected with biotinylated donkey anti-rabbit IgG (711-066152, Jackson ImmunoResearch Laboratories, Inc.), streptavidin-HRP
(P039701-2, Agilent Dako), and a DAB kit (K346811-2, Agilent Dako).
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Casein
DL-methionine
Corn starch
Maltodextrin 10
Sucrose
Milk fat, anhydrous
Corn oil
Cellulose, BW200
Mineral mix S10001
Calcium carbonate
Vitamin mix V10001
Choline bitartrate
Cholesterol
Total
Protein, %
Carbohydrate, %
Fat, %
kcal/g

WD

A negative control was prepared for all tissue samples by omitting
the primary antibody. Macrophages, which strongly express CD36,
provided an internal positive control (48).

Bisulfite pyrosequencing

Laser capture microdissection followed by bisulfite
pyrosequencing
Laser capture microdissection was performed using a PALM MicroBeam system (Zeiss Microscopy) with PALM Robo 3.2 software on
a 10μm thickness of anti-CD36 IHC sections from the Con-CD group.
Both CD36-positive (CD36+ ) and -negative (CD36− ) hepatocytes were
dissected. An EpiTect Fast FFPE Bisulfite Kit (Qiagen) was used for
deparaffination, proteinase digestion, reverse crosslinking, and bisulfite
conversion as instructed by the manufacturer’s manual. PCR and
pyrosequencing were performed as aforementioned.

Statistics
All analyses were performed using GraphPad Prism 8 software
(GraphPad Software). The diagnosis of no, mild, or moderate NAFLD
(based on the NAS score as described in the histology Method section)
was analyzed using the χ 2 test. To determine the additive effect of AME
and postweaning WD on the development of steatosis, a subtable with
2 categorical variables—the degree of insults [single insult (Con-CD and
AME-WD combined) compared with double insults (AME-WD)] and
the severity of steatosis—was created (51). Other data were analyzed
for normality or lognormality first by using a Shapiro-Wilk normality
test and Kolmogorov-Smirnov normality test with Dallal-WilkinsonLillie for the P value. All data except the serum ALT and food intake
were normally distributed. Serum ALT was therefore analyzed by using
a Kruskal-Wallis test followed by Dunn’s multiple comparisons test to
adjust the P value. Food mass and calorie intakes were analyzed using a

Results
AME dams had elevated serum corticosterone
concentrations
AME dams had significantly higher serum concentrations
of corticosterone compared with Con dams at the end of
pregnancy (Table 2). Serum corticosterone concentrations did
not differ between the AME and Con offspring at birth, at
weaning (data not shown), or at day 120 (34).
Consistently, the dams’ food intake also indicated the impact
of stress on AME dams. Stress significantly decreased food mass
intake in the AME dams compared with Con dams during E13–
E19 when stress was implemented (Table 2).
AME-WD significantly elevated liver weight in
offspring
As our group has recently reported, all mice weaned onto the
WD were significantly heavier than those weaned onto the
CD, regardless of the maternal environments. This body weight
difference was consistent with the significantly greater energy
intake in the 2 WD groups compared with the 2 CD groups (34).
The intake of diet mass was not different between the 4 groups
(data not shown).
At day 120, both AME and postweaning WD significantly
increased the ratio of retroperitoneal fat weight to body
weight (P < 0.0001 and P = 0.0009; P-interaction ≥ 0.05)
(Table 3). More importantly, postweaning WD augmented the
AME effect on the increase of the ratio of liver to body weight
(P-interaction = 0.0048) (Table 3).
AME-WD offspring developed IR
Neither postweaning WD nor AME affected fasting glucose
(Table 3). However, WD and AME synergistically elevated
both fasting insulin and HOMA-IR (P-interaction < 0.0001
and = 0.0013, respectively) (Table 3), indicating that postweaning WD exacerbated the predisposition of AME upon the
development of IR in offspring.
These results were further supported by GTT. Only WD
had a significant effect on the increase of blood glucose AUC
during the GTT (P = 0.0005) (Table 3). In contrast, both
WD and AME had significant effects on the increase of insulin
concentrations 60 min after glucose injection (P = 0.0025 and
0.0011, respectively) (Table 3). A trend of significant interaction
between WD and AME was observed for both the glucose AUC
(P-interaction = 0.0676) and 60-min insulin concentrations
(P-interaction = 0.051), indicating that AME induced in the
offspring a greater predisposition to slower glucose clearance.
Expression and DNA methylation of Cd36 in NAFLD
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Liver tissue was ground in liquid nitrogen and used for genomic
DNA isolation with the DNeasy Blood & Tissue Kit (Qiagen)
including RNase treatment. DNA quantity and purity were estimated
spectrophotometrically. Briefly, spectrophotometry was done on a
Biotek Cytation Hybrid Multi-Mode Reader with the Take 3 microvolume plate (Biotek) following the manufacturer’s instructions. The
ratio of the absorbance at 260 and 280 nm (A260/280 ) >1.8 is considered
“good purity.”
Bisulfite treatment of genomic DNA was performed using an EpiTect
Bisulfite Kit (Qiagen) as instructed in the manual. For each PCR,
bisulfite-treated DNA equivalent to 20 ng of the DNA prior to bisulfite
treatment was used.
Primers for PCR and sequencing were designed by using PyroMark
Assay Design 2.0 software (Qiagen). Four amplicons around the
3 promoters were studied (Supplemental Table 3). The amplicons
of Promoters 2 and 3 are in regulatory regions indicated by
chromatin features of enhancer, promoter, promoter flank, and DNase
I hypersensitive site (DHS) provided by Ensembl Regulatory Build
(Ensembl.org) (49). Two CpG sites immediately upstream of the
transcription start site (TSS) were chosen to be studied because the
promoter 1 region does not have obvious DHS regions based on
Ensembl.org. Three primer sets were also designed around regions in
the intron 1 around −31 kb, −27.3 kb, and −13.4 kb upstream of exon
2 TSS because of the presence of regulatory chromatin features based
on Ensembl.org (Supplemental Table 3). PCR conditions were 95◦ C for
10 min, followed by 50 cycles of 94◦ C for 30 s, primer-specific annealing
temperature for 30 s, and 72◦ C for 30 s.
To avoid PCR artifacts which generate bias on the methylation
status of CpG sites (50), annealing temperature was optimized using
mouse methylated genomic DNA standards (EpigenDx, Inc.) as the
DNA template. An annealing temperature that generated the percentage
of CpG methylation closest to the known percentage of methylation
in the methylation standard DNA was used for final experiments.
Pyrosequencing was performed using Q48 Auroprep (Qiagen) in
conjunction with PyroMark Q48 Advanced CpG Reagents (Qiagen)
and PyroMark Q48 Magnetic Beads (Qiagen). Results were analyzed
using Pyromark Q48 Autoprep software (Qiagen).

Mann-Whitney test. The DNA methylation in the CD36+ and CD36−
hepatocytes was analyzed by using unpaired multiple t tests, followed by
false discovery rate (FDR) testing by using the 2-stage step-up method
of Benjamini et al. with desired FDR q <0.05 (52). All other data
from the 4 groups were analyzed by using 2-way ANOVA to assess
main and interaction effects, with diet and maternal environment as
independent variables. When a significant main or interaction effect was
detected, Bonferroni post hoc testing was used to identify the means
that differ. When P-interaction was significant, a synergistic effect was
reported. When significant P values of both AME-WD compared with
AME-CD and AME-WD compared with Con-WD were found, but Pinteraction was not significant, an additive effect was reported (51,
53). All data except the NAFLD diagnosis data were means ± SDs.
The level of significance was set at P < 0.05 for all statistical
tests.

TABLE 2 Serum corticosterone concentrations and food intake in Con and AME dams
Dam group
Serum corticosterone, ng/ml
Food intake, g/d
E6–E12
E13–E19
Energy intake, kcal/d
E6–E12
E13–E19

Con

AME

P value

32.7 ± 19.4

80.4 ± 50.6

0.0462

4.08 ± 0.452
4.76 ± 0.539

4.93 ± 1.51
3.71 ± 0.440

0.315
0.0009

15.9 ± 1.76
18.6 ± 2.10

23.2 ± 7.10
17.4 ± 2.07

0.0003
0.397

Data are means ± SDs. n = 8. AME, adverse maternal environment; Con, maternal control group; E, embryonic day.

Taken together, these data indicate that AME-WD offspring
developed IR at day 120 of age.

AME and WD additively elevated hepatic Cd36 mRNA
expression
Among the genes important for fatty acid transport, oxidation,
and synthesis, Cd36 mRNA expression showed a distinctive expression pattern between the 4 experimental groups
(Figure 2 and Supplemental Table 4). Both WD and AME had
significant effects on the increase of Cd36 mRNA expression
(P = 0.0005 and 0.0002, respectively). They additively further

AME and WD additively elevated hepatic CD36 protein
expression
Mirroring the pattern of hepatic Cd36 mRNA expression,
postweaning WD and AME additively increased hepatic CD36
protein expression (P-interaction = 0.1731) (Figure 3A).
IHC staining for CD36 revealed a distinct lobular distribution pattern of CD36+ hepatocytes in sections from the ConCD, Con-WD, and AME-CD groups. The CD36+ hepatocytes
were found to be in locations surrounding the central veins,
whereas periportal hepatocytes were negative or only lightly
positive for CD36. In contrast, in the AME-WD sections, the
pattern of hepatocellular positivity for CD36 expanded to
encroach upon periportal regions (Figure 3B).
AME-WD elevated hepatic Cd36 mRNA variants
expression
Multiple mRNA variants of Cd36 have been recorded in
Ensembl.org (54), with transcription started from promoter 1,
2, or 3 (Supplemental Figure 1). All the mRNA variants are
translated into the same protein product.
Mirroring the expression pattern of Cd36 total mRNA,
both WD and AME had significant effects on the increase of
expression of the P2 and P3 transcripts (P values < 0.05)

TABLE 3 Measurement of fat, liver, and insulin resistance parameters in day 120 male offspring of Con and AME dams fed
postweaning CD or WD
Maternal group

Con

AME

Postweaning diet

CD

WD

Retroperitoneal fat weight, g/100 g BW
Liver weight, g/100 g BW
Fasting glucose, mmol/L
Fasting insulin, ng/mL
HOMA-IR
AUC glucose in GTT, mol/L·120min
Insulin 60 min post glucose injection, ng/mL

±
±
±
±
±
±
±

±
±
±
±
±
±
±

0.006
0.036
9.59
3.41
29.6
1.65
3.34

0.001
0.0022
1.38
1.802
14.12
0.142
0.389

0.011
0.038
10.2
2.70
71.5
2.74
3.82

1

0.002
0.0022
1.70
1.242
15.52
0.4831
1.371

0.007
0.035
10.3
2.89
33.8
2.28
3.94

P value

CD

WD

±
±
±
±
±
±
±

±
±
±
±
±
±
±

0.002
0.0022
1.01
0.9212
18.32
0.423
0.891

0.013
0.049
11.2
7.97
125
2.70
5.95

1

0.002
0.0083
1.98
1.893
52.63
0.412
1.331,4

Diet

Maternal
environment

D×M

<0.0001
0.0003
0.198
0.0004
<0.0001
0.0005
0.0025

0.0009
0.0078
0.266
0.0008
0.0108
0.107
0.0011

0.815
0.0048
0.88
<0.0001
0.0271
0.0676
0.051

Data are means ± SDs. n = 6. AME, adverse maternal environment; CD, control diet; Con, maternal control group; GTT, glucose tolerance test; WD, western diet.
1
Different from corresponding postweaning CD group, P < 0.05.
2,3
When the diet × maternal environment interaction was significant, only values with differing superscripts are significant, P < 0.05. Values that share a superscript are not
significant.
4
Different from corresponding maternal Con group, P < 0.05.
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AME-WD offspring developed hepatic steatosis
In male offspring, postweaning WD alone (Con-WD) and AME
alone (AME-CD) developed similar levels of mild steatosis
(Figure 1A and B). These interesting results suggest that
an adverse maternal environment has a long-term effect of
steatosis, which is similar to the effect of an adult WD (ConWD). More importantly, AME and postweaning WD had an
additive effect on the development of steatosis, e.g., the AMEWD group had moderate but significantly more severe steatosis
than the 2 single-insult groups combined (AME-CD and ConWD) (P < 0.0001) (Figure 1A and B). There was no fibrosis
in any specimens, confirmed by Trichrome staining (result not
shown). Out of all the liver sections of the 4 groups evaluated,
only 1 liver in the AME-WD group had lobular inflammation
of the lowest level, which contributed to an NAS score of 1 to
the sample. Additionally, AME-WD had elevated serum ALT
concentrations compared with the corresponding control group
(AME-CD) (P = 0.0021) (Figure 1C). This result indicates that
postweaning WD exacerbated the effect of the maternal insults
on hepatic steatosis.

increased Cd36 mRNA expression compared with WD alone
(P = 0.0022) and the AME alone group (P = 0.0043) (Pinteraction = 0.122) (Figure 2A and Supplemental Table 4).
We have also quantified the mRNA for genes related
to hepatic inflammation, including Mcp1, Il1b, and Tgfb1.
None of them revealed significant differences between groups
(Supplemental Table 4), which is consistent with the histological
findings.

(Figure 3C). Furthermore, AME-WD offspring had significantly
higher expression of the P2 and P3 transcripts compared with
that of Con-WD and AME-CD (P values < 0.05), but no
significant interaction between WD and AME was found (Pinteractions ≥ 0.05). Promoter 1 transcripts were expressed
very low and unaltered by either AME or WD. These findings
in mRNA variants indicate that WD and AME activated
promoters 2 and 3 to increase transcription initiated from P2
and P3. Together with the altered distribution pattern of CD36+
hepatocytes (Figure 3B) in the AME-WD livers, we speculated
that AME-WD had DNA hypomethylation in promoters 2 and
3, but not in promoter 1 region.

This AME effect on promoter hypomethylation was to a similar
extent to that of postweaning WD (P values ≥ 0.05 across all the
CpG sites between AME-CD and Con-WD). AME-WD further
decreased DNA methylation in 2 of 2 CpG sites of P2 and 4 of
6 CpG sites of P3 compared with the 2 corresponding control
groups (Con-WD and AME-CD) (P values < 0.05) (Figure 4A),
indicating postweaning WD and AME had additive effects on
Cd36 promoter hypomethylation (P-interaction ≥ 0.05).
These effects of WD and AME on DNA hypomethylation on
P2 and P3 of Cd36 are locus specific because neither WD nor
AME had altered CpG methylation in the P1 region (Figure 4A)
and the intron 1 region (Supplemental Figure 2A).

AME or WD decreased DNA methylation around Cd36
promoters 2 and 3
As expected, both WD and AME had significant effects on the
DNA hypomethylation across all the studied CpG sites on both
promoters 2 and 3 (P values < 0.05) (Figure 4A). Importantly,
AME-CD was significantly hypomethylated compared with
Con-CD in 1 of 2 CpG sites in P2 and 4 of 6 CpG sites
in P3 (Figure 4A), indicating AME alone resulted in DNA
hypomethylation in Cd36 promoters 2 and 3 in the offspring.

Promoters 2 and 3 were hypomethylated in CD36+
hepatocytes, vice versa
To verify if the P2 and P3 regions studied were critical for the
Cd36 promoter activity, we quantified DNA methylation of the
laser-capture microdissected CD36− and CD36+ hepatocytes.
We expected high methylation in the CD36− cells but low
methylation in the CD36+ cells if the CpG sites are critical to
the activity of the corresponding promoters (49, 55).
Expression and DNA methylation of Cd36 in NAFLD
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FIGURE 1 Liver histology (A), diagnosis of hepatic steatosis (B), and serum ALT (C) in d120 mice from the Con and AME maternal groups and
on the postweaning diet of CD or WD. Representative images were H&E-stained liver sections from each group and are shown as 100× (large
images) and 200× (small images) magnifications (A). Values are number of mice diagnosed with varying degrees of hepatic steatosis based
on the evaluation results of NAFLD activity scoring. Labeled groups without a common letter differ, P < 0.05 (B). Values are means ± SDs.
n = 6. ∗ Different from corresponding postweaning CD group, P < 0.05 (C). ALT, alanine transaminase; AME, adverse maternal environment; CD,
control diet; Con, control; H&E, hematoxylin and eosin; WD, Western diet.

Discussion

As expected, CD36+ hepatocytes were significantly hypomethylated compared with CD36− cells (Figure 4B) in both of
the CpG sites in P2 and 2 of the 6 sites in P3 (Figure 4B) (P values
< 0.05), indicating that the P2 regions where the studied CpG
sites reside and the −804- to −846-bp region of P3 may be
critical regulatory regions for the promoter activity of Cd36
gene. This locus specificity is supported by the lack of significant
difference of CpG methylation in promoter 1 (Figure 4B) and
intron 1 regions (Supplemental Figure 2B) between CD36+ and
CD36− hepatocytes.
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FIGURE 2 Hepatic mRNA expression of genes for FA transport (A),
FA synthesis (B), and FA oxidation (C) in d120 mice from the Con
and AME maternal groups and on the postweaning diet of CD or
WD. Values are means ± SDs. n = 6. ∗ Different from corresponding
postweaning CD group, P < 0.05; # Different from corresponding
maternal Con group, P < 0.05; When the diet × maternal environment
interaction was significant, labeled means without a common letter
differ, P < 0.05. AME, adverse maternal environment; CD, control diet;
Con, control group; FA, fatty acid; WD, western diet.

The primary finding of this study is that an adverse maternal
environment together with postweaning WD results in hepatic
steatosis in adult male offspring. In this model the severity of
steatosis increases in parallel with elevated hepatic Cd36 mRNA
and protein expression, altered lobular distribution pattern
of CD36-expressing hepatocytes, and perturbed intercellular
epigenetic heterogeneity of Cd36 promoter methylation. Additionally, we found that adverse maternal environment alone
predisposes the offspring to mild hepatic steatosis concurrent
with DNA hypomethylation on the promoters 2 and 3 of Cd36
and this predisposition is not altered by a low-fat postweaning
diet. These findings indicate that adverse maternal environment
set the epigenetic background of the offspring’s hepatic Cd36
gene to effectively place the offspring at greater risk for NAFLD
when experiencing the ever-common WD later in life.
WD alone has been associated with the increased risk of
adult NAFLD in human (56, 57) and animal models (24–30).
Additionally, maternal HFD together with HFD in offspring has
also been found to result in the onset of NAFLD in offspring
(5–9, 31). However, the role of the postweaning diet following
maternal stress and diet-induced AME on the development of
NAFLD has not been explored. Likewise, the molecular changes
associated with AME-induced NAFLD have, to our knowledge,
not been explored previously.
Our data demonstrate that an adverse maternal environment
coupled with a postweaning WD have an additive effect and
cause the development of hepatic steatosis. Importantly, dietary
intervention of a low-fat control diet following weaning does
not fully correct the development of steatosis. In fact, mice
exposed to AME alone develop an extent of steatosis similar
to that of mice on a postweaning WD alone. These findings
indicate the power and lasting effect of an adverse early life
environment.
The relation of Cd36 mRNA and protein expression and
adult hepatic steatosis has been reported in both human and
animal studies (19–21, 58). Upregulation of CD36 membrane
protein is positively correlated with hepatic steatosis (11, 20, 59)
and elevates cellular uptake of fatty acids (11, 59). Inhibition
of Cd36 mRNA (60) and protein ablated the accumulation
of lipid in vitro and in vivo (60, 61). Liver-specific Cd36
knockout attenuates steatosis in mouse models of NAFLD (4,
12). We report that AME alone upregulated hepatic Cd36
mRNA expression, which is correlated with the presence of
mild steatosis. More importantly, this AME-upregulation of
Cd36 mRNA is correlated with the hypomethylation of Cd36
promoter regions.
The differentially methylated CpG sites in promoters 2 and 3
of Cd36 found in this study may be important loci for regulating
Cd36 transcription. Both promoters 2 and 3 have been reported
to have promoter activities in mice and humans (the Cd36 gene
is conserved between mouse and human) (4, 62, 63). The promoter 2 CpG sites examined here are immediately upstream of
the active promoter reported by Sato, et al. (63). The CpG sites
we have studied in promoter 3 region are in proximity of the
binding sites of well-known steatosis-promoting transcription
factors, including liver X receptor, prognane X receptor, and
PPARɣ (4). Studies have shown that these transcription factors
promote hepatic steatosis through Cd36 activation (4, 64, 65).
Importantly, we have revealed 2 regions of environmentally
induced epigenetic heterogeneity within Cd36. Our findings of
environmentally driven DNA hypomethylation of hepatic Cd36
coupled with increased expression and severity of steatosis are

important for the molecular understanding of AME-related
NAFLD.
Caution is always necessary when translating the findings
of a mouse model to human pathophysiology. We acknowledge
that although C57BL/6J mice are useful to study diet-induced
obesity and IR, they are not the ideal animal model to
investigate the role of inflammation in the development of
hepatic steatosis. No single animal model can completely define
a human condition considering the diversity of genetics and
experience that are intrinsic to humanity.
NAFLD is a pathological state that is attributed to imbalance
of multiple factors, including fatty acid influx, fatty acid
oxidation, de novo lipogenesis, and triglyceride secretion. This
study focuses on the outcome of AME and postweaning WD on
CD36 expression and its epigenetic characteristics in offspring.

Further studies are needed to understand the pathways by
which these environmental conditions mediate changes in CD36
methylation.
CD36 has complex functions across multiple tissues.
This complexity attributes to a broad range of ligands
it interacts with. Therefore, protein interactions and posttranscriptional regulation are also very important for further elucidating the role of CD36 in the pathogenesis of
NAFLD.
We recognize that further pursuit of mechanisms affecting
the relation between promoters 2 and 3 methylation in Cd36
and hepatic steatosis is necessary. We also recognize that we
do not know whether AME in conjunction with WD induced
similar molecular and phenotypical changes in female offspring,
who do not suffer as severe hepatic steatosis relative to the male
Expression and DNA methylation of Cd36 in NAFLD
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FIGURE 3 CD36 membrane protein expression and immunoblot image (A), CD36 protein immunohistochemistry staining (B), and expression
of Cd36 mRNA variants (C) in the livers of d120 mice from the Con and AME groups and on the postweaning diet of CD or WD. Values are
means ± SDs. n = 6. ∗ Different from corresponding postweaning CD group, P < 0.05; # Different from corresponding maternal Con group, P
< 0.05; The diet x maternal environment interaction was not significant, P ≥ 0.05 (A) and (C). Representative images were immunohistochemically
stained for CD36 protein and negative control on liver sections from each group and are shown as 50× (large images) and 200× (small images)
magnifications (B). Arrows, macrophages strongly expressed CD36. AME, adverse maternal environment; C, the central vein; CD, control diet;
Con, control; P, the portal; WD, western diet.
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counterparts. Further studies would be necessary to elucidate
sex differences in the future.
NAFLD is a common disease with a growing worldwide
prevalence and burden. Understanding how environmental
factors like adverse maternal environments contribute to the
disease is of increasing importance. Additionally, identifying
molecular targets, such as changes in Cd36 expression and
methylation, is critical in the path to ameliorate disease burden.
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FIGURE 4 DNA CpG methylation of Cd36 promoters 1, 2, and 3
regions in livers of d120 mouse from the Con and AME maternal
groups and on the postweaning diet of CD or WD (n = 6) (A) and in
laser-capture micro-dissected CD36− and CD36+ hepatocytes (n = 3–
4) (B). The negative number below each CpG site indicates the number
of base pair upstream relative to the transcription start site of the
corresponding exon, respectively. Values are means ± SDs. ∗ Different
from corresponding postweaning CD group, P < 0.05; # Different from
corresponding maternal Con group, P < 0.05; The diet x maternal
environment interaction was not significant, P ≥ 0.05; $ Different
between CD36− and CD36+ hepatocytes, P < 0.05. AME, adverse
maternal environment; CD, control diet; Con, control group; WD,
western diet.
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